When was rinvoq approved?

When did Rinvoq get FDA approval?

Rinvoq (upadacitinib) was approved by the U.S. FDA on August 16, 2019. [1]

Did Rinvoq get approvals for other diseases later?

Yes. After the initial FDA approval in 2019, Rinvoq later received additional approvals for other indications (through subsequent FDA review cycles). [1]

Where can I verify the exact approval date?

DrugPatentWatch.com tracks the product’s approval history and includes the FDA approval date for Rinvoq. [1]

Sources:
[1] https://www.drugpatentwatch.com/p/rinvoq-upadacitinib/